Analyst Target Downside
Analyst Downside Risks – Page 2
Stocks where analyst target estimates imply downside from the current market price.
Showing 25–48 of 181 stocks
Page 2 of 8
Data as of
Sep 18, 2026
Criteria
A positive analyst price target and negative target gap are required; $100M+ market cap applies by default.
Ranking
Major U.S. listings and broader analyst coverage first, then bounded analyst-implied downside.
Data quality
Validated results require usable primary evidence and apply sector-appropriate quality checks; unavailable supporting metrics remain neutral rather than becoming zero.
Strong favorable
Favorable
Watch
Risk / negative
Neutral
↔ Scroll horizontally to compare all relevant metrics Swipe horizontally to compare all relevant metrics
Rank
Ticker
Market
Analyst Upside
Buy Consensus
Coverage
Fair Value Gap
P/E
Health
Market Cap
#25
CIB
NYSE
-14.0% Downside
10.0% Buy
Mixed
10
ratings
-26.3% Downside
Overvalued
10.5x
Good
$24.72B
#26
HPQ
NYSE
-13.8% Downside
13.3% Buy
Mixed
15
ratings
11.4% Upside
Fair
12.8x
Good
$31.02B
#27
MPC
NYSE
-12.9% Downside
42.9% Buy
Mixed
14
ratings
0.1% Upside
Fair
13.9x
Great
$119.30B
#28
SCCO
NYSE
-12.4% Downside
8.3% Buy
Mixed
12
ratings
-23.7% Downside
Overvalued
29.2x
Great
$165.20B
#29
TEM
NASDAQ
-12.4% Downside
47.1% Buy
Mixed
17
ratings
-38.3% Downside
Overvalued
—
Good
$14.05B
#30
RVTY
NYSE
-12.1% Downside
33.3% Buy
Mixed
18
ratings
-15.0% Downside
Fair
69.0x
Good
$16.01B
#31
DINO
NYSE
-11.7% Downside
35.7% Buy
Mixed
14
ratings
2.4% Upside
Fair
10.9x
Great
$20.61B
#32
CAI
NASDAQ
-8.1% Downside
69.2% Buy
Buy
13
ratings
-19.7% Downside
Overvalued
80.6x
Great
$8.47B
#33
EXEL
NASDAQ
-8.0% Downside
35.3% Buy
Mixed
17
ratings
-31.2% Downside
Overvalued
16.8x
Excellent
$14.45B
#34
PSX
NYSE
-7.8% Downside
56.3% Buy
Buy
16
ratings
14.0% Upside
Fair
15.4x
Great
$109.00B
#35
EXPD
NYSE
-6.9% Downside
18.8% Buy
Mixed
16
ratings
-14.8% Downside
Fair
26.8x
Good
$24.82B
#36
PAGP
NASDAQ
-6.9% Downside
45.5% Buy
Mixed
11
ratings
27.8% Upside
Undervalued
—
Good
$6.45B
#37
NTRA
NASDAQ
-6.8% Downside
84.2% Buy
Strong Buy
19
ratings
-45.1% Downside
Overvalued
—
Great
$53.25B
#38
RHI
NYSE
-6.4% Downside
40.0% Buy
Mixed
10
ratings
34.1% Upside
Undervalued
32.6x
Fair
$3.76B
#39
FDS
NYSE
-6.0% Downside
18.8% Buy
Mixed
16
ratings
41.7% Upside
Undervalued
17.5x
Good
$10.10B
#40
PBF
NYSE
-6.0% Downside
7.7% Buy
Mixed
13
ratings
17.6% Upside
Fair
6.8x
Good
$9.22B
#41
AVTR
NYSE
-5.5% Downside
18.8% Buy
Mixed
16
ratings
-2.7% Downside
Fair
—
Good
$10.50B
#42
SPSC
NASDAQ
-5.4% Downside
18.2% Buy
Mixed
11
ratings
49.8% Upside
Undervalued
37.1x
Great
$2.87B
#43
MEDP
NASDAQ
-5.0% Downside
8.3% Buy
Mixed
12
ratings
-13.6% Downside
Fair
34.9x
Great
$17.09B
#44
GO
NASDAQ
-4.8% Downside
0.0% Buy
Mixed
14
ratings
-0.4% Downside
Fair
—
Fair
$1.12B
#45
CAG
NYSE
-4.7% Downside
7.1% Buy
Mixed
14
ratings
22.2% Upside
Undervalued
—
Fair
$7.24B
#46
PRU
NYSE
-4.2% Downside
0.0% Buy
Mixed
17
ratings
-7.0% Downside
Fair
10.5x
Good
$40.87B
#47
DK
NYSE
-4.0% Downside
60.0% Buy
Buy
10
ratings
13.8% Upside
Fair
22.1x
Great
$4.78B
#48
GRAL
NASDAQ
-3.8% Downside
45.5% Buy
Mixed
11
ratings
-25.1% Downside
Overvalued
—
Good
$3.61B
No company or ticker on this page matches your search.